Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Chronic Lymphocytic Leukemia

Breast Cancer

Gastrointestinal Cancer

Chronic Lymphocytic Leukemia

O'Brien Shares Overview of CLL Sequencing

Susan M. O'Brien, MD, discusses some of the latest intriguing data in the treatment of chronic lymphocytic leukemia and what this means for physicians and patients.
Read More >>

Rai Helped Launch an Age of Innovation in Leukemia

Talley Traces Developments in Chronic Leukemias

Expert Reviews Current State of CLL Treatment

Umbralisib Shows Promise in Relapsed/Refractory CLL

CF HEM 2018: Expert Shares Insights on CLL Treatment Paradigm

View More Stories >>

View Conference Coverage

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

2018 State of the Science Summit on Breast Cancer

Dr. Brander Discusses the Frontline Treatment of CLL

Dr. Barrientos on Advances in the Treatment Landscape for Patients With CLL

Dr. O'Brien on Sequencing Small Molecule Inhibitors in CLL

Dr. Talley on Clinical Trials for Patients With Chronic Leukemias

Dr. Talley on the CAPTIVATE Trial in CLL

Dr. Mato Discusses a Phase II Trial of Umbralisib in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Evaluating CAR T-Cell Therapy Use

The Role of Transplant and Future of CLL

Other Promising Strategies in CLL

Maintenance and Frontline Therapy in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Evolving Treatment Landscape of CLL

$Relapsed/Refractory CLL: Evaluating Other Novel Agents$

Relapsed/Refractory CLL: Evaluating Other Novel Agents

$Novel Approaches to Treating Relapsed/Refractory CLL$

Novel Approaches to Treating Relapsed/Refractory CLL

$Continuing Therapy in Relapsed/Refractory CLL$

$Evaluating Pharmacologic Agents in Relapsed/Refractory CLL$

CLL: Post-Ibrutinib or Chemoimmunotherapy Approaches

$Approaching Therapy for Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Other Promising Strategies in CLL

This expert panel discussion led by William Wierda, MD, focuses on promising strategies available for the treatment of chronic lymphocytic leukemia. Dr. Wierda is joined in this discussion by Steven Coutre, MD; Matthew S. Davids, MD, MMSc; Nicole Lamanna, MD; and Shuo Ma, MD, PhD.

View Now

The Use of Novel PI3K Inhibitors in CLL

In this segment William Wierda, MD, PhD, leads a panel discussion regarding the use of novel PI3K inhibitors in chronic lymphocytic leukemia.

View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More